RETRACTION: Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H2S‐Nrf2 signaling

Documenti analoghi

• Borolatonin limits cognitive deficit and neuron loss while increasing proBDNF in ovariectomised rats
  di: Mónica Barrón‐González, et al.
  Pubblicazione: (2024)
• The role of β‐adrenergic receptors in the regulation of cardiac tolerance to ischemia/reperfusion. Why do β‐adrenergic receptor agonists and antagonists protect the heart?
  di: Leonid N. Maslov, et al.
  Pubblicazione: (2024)
• Fluvoxamine Attenuates Liver Injury in Lipopolysaccharide‐Induced Sepsis: Via Nrf2/HO‐1 Pathway
  di: Rahime Aslankoc, et al.
  Pubblicazione: (2025)
• Dual ETA‐ETB receptor antagonism improves metabolic syndrome‐induced heart failure with preserved ejection fraction
  di: Francesca Lockwood, et al.
  Pubblicazione: (2025)
• Mechanism research on microRNA‐669f‐5p/deoxycytidylate deaminase axis mediating sevoflurane‐induced cognitive dysfunction in aged mice
  di: Yuan‐Ping Zhong, et al.
  Pubblicazione: (2024)